期刊文献+

小蘖碱抑制游离脂肪酸诱导小鼠肝实质细胞脂肪变性 被引量:1

Berberine Inhibits the Steatosis of Parenchymal Hepacyto Induced by FFAs
原文传递
导出
摘要 目的:探讨小蘖碱(Berberine)对游离脂肪酸(free fatty acids,FFAs)诱导的小鼠肝实质细胞脂肪变性的影响。方法:胶原酶灌注分离BALB/c小鼠原代肝实质细胞并体外培养。分对照组,高脂组,高脂加小蘖碱处理组。体外测定细胞内甘油三酯的含量。利用油红染色观察细胞的脂肪样变性。通过Western印迹法检测肝实质细胞内MAPK相关信号通路磷酸化的变化。实时定量PCR检测肝实质细胞中与脂肪化密切相关的mi R-122的表达和相关靶基因的表达改变。结果:与高脂组比较,小蘖碱处理组肝实质细胞内甘油三酯含量降低,脂肪颗粒减少,脂肪变性明显改善,并具有明显的剂量效应,小蘖碱能够抑制FFAs诱导的JNK通路磷酸化。Q-PCR结果表明小蘖碱能够促进肝实质细胞内mi R-122的表达,并降低脂肪化相关基因Dgat2的表达。结论:小蘖碱能够显著改善高脂诱发的肝脂肪变性,抑制JNK通路磷酸化,其机制可能同mi R-122通路相关。 Objective: To research the influence of Berberine on liver steatosis induced by free fatty acids(free fatty acids, FFAs)from liver parenchymal cells. Methods: Mouse primary hepatocytes were isolated by a two-step collegenase perfusion procedure and cultured in vitro. Cells were divided into three groups, the control group, FFAs group and FFAs plus berberine treatment group. The content of triglyceride was determined in vitro. Steatosis was analyzed by oil red O staining. The MAPK related signal pathway was analyzed by Western-blot assay. Real-time PCR was used to detect the expression of mi R-122 which was closely related to fat and relevant target genes in liver parenchymal cells. Results: Compared with FFAs group, berberine treatment decreased the content of triglyceride and fat particles significantly and improved steatosis obviously in liver parenchymal cells in a dose-dependent manner. Berberine could effectively inhibit phosphorylation of JNK pathway induced by FFAs. Q-PCR results showed that berberine could up-regulate the expression of mi R-122 while down-regulate the expression of Dgat2. Conclusions: Berberine can significantly improve the steatosis induced by FFAs and inhibit phosphorylation of JNK pathway by a possible mechanism of mi R-122 pathway.
出处 《现代生物医学进展》 CAS 2015年第1期14-17,32,共5页 Progress in Modern Biomedicine
基金 重大科学仪器研究专项(2013YQ140405) 国家自然科学基金青年学者基金项目(31000405) 国家高技术研究发展计划(2012AA020201) 科技重大专项(2013ZX10002009-001)
关键词 小蘖碱 游离脂肪酸 肝实质细胞 脂肪变性 Berberine FFAs Hepatocyte Steatosis
  • 相关文献

参考文献25

  • 1Moore JB. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome[J]. Proe Nutr Soc, 2010, 69(2): 211-220.
  • 2陆灏,叶伟成,丁学屏.黄连素对实验大鼠胰岛素抵抗的影响[J].辽宁中医学院学报,2002,4(4):259-260. 被引量:59
  • 3魏敬,吴锦丹,蒋建东,王书奎,王自正.盐酸小檗碱治疗2型糖尿病合并脂肪肝的临床研究[J].中西医结合肝病杂志,2004,14(6):334-336. 被引量:38
  • 4Zhang B J, Xu D, Guo Y, et al. Protection by and anti-oxidant mecha- nism of berberine against rat liver fibrosis induced by multiple hepa- totoxic factors[J]. Clin Exp Pharmacol Physiol, 2008, 35(3): 303-309.
  • 5Zhang X, Yang J, Guo Y, et al. Functional proteomic analysis of non- alcoholic fatty liver disease in rat models:enoyl-coenzyme a hy- dratase down-regulation exacerbates hepatic steatosis[J]. Hepatology, 2010, 51(4): 1190-1199.
  • 6Sabio G, Cavanagh-Kyros J, Ko HJ, et al. Prevention of steatosis by hepatic JNK1 [J]. Cell Metab, 2009, 10(6): 491-498.
  • 7Esau C, Davis S, Murray SF, et al. MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting [J]. Cell Metab, 2006, 3(2): 87-98.
  • 8Wurie HR, Buckett L, Zammit VA. Diacylglycerol acyltransferase 2 acts upstream of diacylglycerol acyltransferase 1 and utilizes nascent diglycerides and de novo synthesized fatty acids in HepG2 cells [J]. FEBS J, 2012, 279(17): 3033-3047.
  • 9Yen CL, Stone SJ, Koliwad S, et al. Thematic review series: glyc- erolipids. DGAT enzymes and triacylglycerol biosynthesis[J]. J Lipid Res, 2008, 49(11): 2283-2301.
  • 10Dormelly KL, Smith CI, Schwarzenberg SJ, et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with non- alcoholic fatty liver disease[J]. J Clin Invest, 2005, 115(5): 1343-1351.

二级参考文献32

共引文献108

同被引文献32

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部